Shigeo Takenaka

Prof. Dr. Shigeo Takenaka

orcid

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 January 2014 in Journal of Agricultural and Food Chemistry
Verified
Journal Article
Closed access
FTFei Teng
Fei Teng
TBTomohiro Bito
Tomohiro Bito
STShigeo Takenaka
Shigeo Takenaka
YYYukinori Yabuta
Yukinori Yabuta
FWFumio Watanabe
Fumio Watanabe

6 July 2011 in Chemical Research in Toxicology
Verified
Journal Article
Open access
TSTsutomu Shimada
Tsutomu Shimada
NMNorie Murayama
Norie Murayama
KTKatsuhiro Tanaka
Katsuhiro Tanaka
STShigeo Takenaka
Shigeo Takenaka
FGFrederick Peter Guengerich
Frederick Peter Guengerich
MKMasayuki Komori
Masayuki Komori
Several organoselenium compounds including benzyl selenocyanate (BSC), 1,2-phenylenebis(methylene)selenocyanate (o-XSC), 1,3-phenylenebis(methylene)selenocyanate (m-XSC), and 1,4-phenylenebis(methylene)selenocyanate (p-XSC) have been shown to prevent cancers caused by polycyclic aromatic hydrocarbons (PAHs) and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in experimental animals; these chemical carcinogens are activated by human P450 1 and 2A family enzymes, respectively, to carcinogenic metabolites. In this study, we examined whether these selenium compounds interact with and inhibit human P450 1 and 2A enzymes in vitro. Four organoselenium compounds induced reverse Type I binding spectra with P450 1A1, 1A2, and 1B1 and Type I binding spectra with P450 2A6 and 2A13. The spectral dissociation constants (Ks) for the interaction of P450 1B1 with these chemicals were 3.6–5.7 μM; the values were lower than those with seen with P450 1A1 (19–30 μM) or 1A2 (6.3–13 μM). The Ks values for Type I binding of P450 2A13 with m-XSC and BSC were both 0.20 μM; the values were very low compared to those for the interaction of P450 2A6 with m-XSC (5.7 μM) and BSC (2.0 μM). Four selenium compounds directly inhibited 7-ethoxyresorufin O-deethylation activities catalyzed by P450 1A1, 1A2, and 1B1 with IC50 values <1.0 μM, except for the inhibition of P450 1A2 by BSC (1.3 μM). Coumarin 7-hydroxylation activities of P450 2A13 were more inhibited by four selenium compounds than those of P450 2A6, with IC50 values of 0.22–1.4 μM for P450 2A13 and 2.4–6.2 μM for P450 2A6. Molecular docking studies of the interaction of four organoselenium compounds with human P450 enzymes suggest that these chemicals can be docked into the active sites of these human P450 enzymes and that the sites of the selenocyanate functional groups of these chemicals differ between the P450 1 and 2A family enzymes.

21 July 2017 in Xenobiotica
Verified
Journal Article
Open access
TSTsutomu Shimada
Tsutomu Shimada
NMNorie Murayama
Norie Murayama
KKKensaku Kakimoto
Kensaku Kakimoto
STShigeo Takenaka
Shigeo Takenaka
YLYoung-Ran Lim
Young-Ran Lim
MKMasayuki Komori
Masayuki Komori
1. 1-Chloropyrene, one of the major chlorinated polycyclic aromatic hydrocarbon contaminants, was incubated with human cytochrome P450 (P450 or CYP) enzymes including CYP1A1, 1A2, 1B1, 2A6, 2A13, 2B6, 2C9, 2D6, 2E1, 3A4 and 3A5. Catalytic differences in 1-chloropyrene oxidation by polymorphic two CYP1B1 and five CYP2A13 allelic variants were also examined. 2. CYP1A1 oxidized 1-chloropyrene at the 6- and 8-positions more actively than at the 3-position, while both CYP1B1.1 and 1B1.3 preferentially catalyzed 6-hydroxylation. 3. Five CYP2A13 allelic variants oxidized 8-hydroxylation much more than 6- and 3-hydroxylation, and the variant CYP2A13.3 was found to slowly catalyze these reactions with a lower kcat value than other CYP2A13.1 variants. 4. CYP2A6 catalyzed 1-chloropyrene 6-hydroxylation at a higher rate than the CYP2A13 enzymes, but the rate was lower than the CYP1A1 and 1B1 variants. Other human P450 enzymes had low activities towards 1-chloropyrene. 5. Molecular docking analysis suggested differences in the interaction of 1-chloropyrene with active sites of CYP1 and 2 A enzymes. In addition, a naturally occurring Thr134 insertion in CYP2A13.3 was found to affect the orientation of Asn297 in the I-helix in interacting with 1-chloropyrene (and also 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, NNK) and caused changes in the active site of CYP2A13.3 as compared with CYP2A13.1.

1 January 2014 in Journal of Veterinary Medical Science
Verified
Journal Article
Open access
RTReo Tamai
Reo Tamai
MFMasaru Furuya
Masaru Furuya
SHShingo Hatoya
Shingo Hatoya
HAHideo Akiyoshi
Hideo Akiyoshi
RYRyohei Yamamoto
Ryohei Yamamoto
STShigeo Takenaka
Shigeo Takenaka
Canine lymphoma is a common cancer that has high rates of complete remission with combination chemotherapy. However, the duration of remission varies based on multiple factors, and there is a need to develop a method for early detection of recurrence. In this study, we compared the metabolites profiles in serum from 21 dogs with lymphoma and 13 healthy dogs using gas chromatography mass spectrometry (GC-MS). The lymphoma group was separated from the control group in an orthogonal projection to latent structure with discriminant analysis (OPLS-DA) plot using ions of m/z 100-600, indicating that the metabolites profiles in lymphoma cases differed from those in healthy dogs. The lymphoma group was also separated from the control group on OPLS-DA plot using 29 metabolites identified in all serum samples. Significant differences were found for 16 of these metabolites with higher levels in the lymphoma group for 15 of the metabolites and lower levels for inositol. An OPLS-DA plot showed separation of the lymphoma and healthy groups using these 16 metabolites only. These results indicate that metabolites profile with GC-MS may be a useful tool for detection of potential biomarker and diagnosis of canine lymphoma.

1 January 2012 in Journal of Nutritional Science and Vitaminology
Verified
Journal Article
Open access
PDF file
EHEri Hashimoto
Eri Hashimoto
YYYukinori Yabuta
Yukinori Yabuta
STShigeo Takenaka
Shigeo Takenaka
YYYuji Yamaguchi
Yuji Yamaguchi
HTHiroyuki Takenaka
Hiroyuki Takenaka
FWFumio Watanabe
Fumio Watanabe
Vitamin B12 content of an edible cyanobacterium, Nostochopsis sp. was determined to be 140.6±16.2 μg/100 g dry weight by a microbiological method. To evaluate whether the Nostochopsis cells contain vitamin B12 or inactive corrinoid compounds, corrinoid compounds were purified from the cells and then identified as pseudovitamin B12 (97.4±11.8 μg/100 g dry weight) and vitamin B12 (43.2±6.0 μg/100 g dry weight) on the basis of silica gel 60 TLC bioautograms and LC/ESI-MS/MS chromatograms. Vitamin B12 content was significantly increased in the Nostochopsis cells (254.8±17.6 μg/100 g dry weight) grown in the vitamin B12-supplemented medium.

1 January 1994 in Bioscience, Biotechnology, and Biochemistry
Verified
Journal Article
Closed access
KMKazutaka Miyatake
Kazutaka Miyatake
GKGoro Kensho
Goro Kensho
TFTadashi Fujimoto
Tadashi Fujimoto
ENEriko Noguchi
Eriko Noguchi
MSMakiko Shinohara
Makiko Shinohara
YNYoshihisa Nakano
Yoshihisa Nakano